bluuebunny/crossref_metadata_2025_split huggingface dataset:
Pre- and peroperative diagnosis of Cutibacterium acnes infections in shoulder surgery: A systematic review
Authors: Pruijn Nathalie , Schuncken Antonius CH , Kosse Nienke M , Hofstad Cheriel J , Dorrestijn Oscar 
Published: May 2020

Background Cutibacterium acnes is the most commonly detected pathogen during shoulder surgery. Lack of typical infection signs make Cutibacterium acnes infections difficult to diagnose. This systematic review aims to determine which pre- and peroperative diagnostic tools are most reliable to identify Cutibacterium acnes infections after shoulder surgery. Methods PubMed/Embase were searched for diagnostic studies. Methodological quality of included studies was assessed using QUADAS-2. Forest plots summarized results (sensitivity and specificity) for each pre- and peroperative diagnostic tool. Results Twenty-two studies were included, of which 8 described preoperative, 10 peroperative, and 4 both pre- and peroperative diagnostic tools. Quality of the studies varied widely. For preoperative tools, synovial calprotectin, interleukin-6, and combined interleukin-6/interleukin-2/tumor necrosis factor-α had the best efficacy measures. Pre-revision biopsies and arthroscopic tissue cultures were the best peroperative tools. Conclusion Despite a lack of evidence and the use of different Cutibacterium acnes infection criteria and reference standards, the use of combined interleukin-6/interleukin-2/tumor necrosis factor-α as preoperative and arthroscopic tissue cultures as peroperative diagnostic tool is for now recommended based on results and validity. More research should be performed to provide valid evidence on these tools. In order to do so, an internationally accepted definition of Cutibacterium acnes infections is essential. Level of evidence Systematic review.
Chondroitinase ABC Enhances Integration of Self-Assembled Articular Cartilage, but Its Dosage Needs to Be Moderated Based on Neocartilage Maturity
Authors: Link Jarrett M. , Hu Jerry C. , Athanasiou Kyriacos A. 
Published: May 2020

Objective To enhance the in vitro integration of self-assembled articular cartilage to native articular cartilage using chondroitinase ABC. Design To examine the hypothesis that chondroitinase ABC (C-ABC) integration treatment (C-ABCint) would enhance integration of neocartilage of different maturity levels, this study was conducted in 2 phases. In phase I, the impact on integration of 2 treatments, TCL (TGF-β1, C-ABC, and lysyl oxidase like 2) and C-ABCint, was examined via a 2-factor, full factorial design. In phase II, construct maturity (2 levels) and C-ABCint concentration (3 levels) were the factors in a full factorial design to determine whether the effective C-ABCint dose was dependent on neocartilage maturity level. Neocartilages formed or treated per the factors above were placed into native cartilage rings, cultured for 2 weeks, and, then, integration was studied histologically and mechanically. Prior to integration, in phase II, a set of treated constructs were also assayed to provide a baseline of properties. Results In phase I, C-ABCint and TCL treatments synergistically enhanced interface Young’s modulus by 6.2-fold ( P = 0.004) and increased interface tensile strength by 3.8-fold ( P = 0.02) compared with control. In phase II, the interaction of the factors C-ABCint and construct maturity was significant ( P = 0.0004), indicating that the effective C-ABCint dose to improve interface Young’s modulus is dependent on construct maturity. Construct mechanical properties were preserved regardless of C-ABCint dose. Conclusions Applying C-ABCint to neocartilage is an effective integration strategy with translational potential, provided its dose is calibrated appropriately based on implant maturity, that also preserves implant biomechanical properties.
Mechanisms of pain in sickle cell disease
Authors: Takaoka Kensuke , Cyril Asha Caroline , Jinesh Sandhya , Radhakrishnan Rajan 
Published: May 2020

Objectives: The hallmark of sickle cell disease (SCD) is acute and chronic pain, and the pain dominates the clinical characteristics of SCD patients. Although pharmacological treatments of SCD targeting the disease mechanisms have been improved, many SCD patients suffer from pain. To overcome the pain of the disease, there have been renewed requirements to understand the novel molecular mechanisms of the pain in SCD. Methods: We concisely summarized the molecular mechanisms of SCD-related acute and chronic pain, focusing on potential drug targets to treat pain. Results: Acute pain of SCD is caused by vaso-occulusive crisis (VOC), impaired oxygen supply or infarction-reperfusion tissue injuries. In VOC, inflammatory cytokines include tryptase activate nociceptors and transient receptor potential vanilloid type 1. In tissue injury, the secondary inflammatory response is triggered and causes further tissue injuries. Tissue injury generates cytokines and pain mediators including bradykinin, and they activate nociceptive afferent nerves and trigger pain. The main causes of chronic pain are from extended hyperalgesia after a VOC and central sensitization. Neuropathic pain could be due to central or peripheral nerve injury, and protein kinase C might be associated with the pain. In central sensitization, neuroplasticity in the brain and the activation of glial cells may be related with the pain. Discussion: In this review, we summarized the molecular mechanisms of SCD-related acute and chronic pain. The novel treatments targeting the disease mechanisms would interrupt complications of SCD and reduce the pain of the SCD patients.
Evidence-Based Policies in Education: Initiatives and Challenges in Europe
Authors: Pellegrini Marta , Vivanet Giuliano 
Published: May 2020

Purpose: This article examines the state of progress of evidence-based educational policies in Europe and identifies organizations for the generation and dissemination of evidence. Further, it discusses some of the most relevant challenges facing the development of evidence-informed education policies in Europe. Design/Approach/Methods: This article analyzes official documents by the European Commission (EC) and other organizations. Literature in the field of evidence-based education worldwide is examined to identify the primary challenges and issues related to the development of a culture of evidence in Europe’s education sector. Findings: The EC has recently prioritized evidence-informed policy and practice in education, increasingly encouraging member states to utilize evidence in the policy decision-making process. According to official documents, this process began in 2006 and has since enjoyed remarkable progress through several initiatives intended to spread a culture of evidence in education. However, several challenges and issues remain regarding the promotion of evidence-informed policymaking. Originality/Value: Having prioritized evidence-informed policy and practice, the EC strongly encourages the adoption of evidence in the policymaking process. This article provides a point of reference regarding the initiatives already undertaken and the challenges facing evidence-based educational policies and policymaking in Europe.
New arsenate minerals from the Arsenatnaya fumarole, Tolbachik volcano, Kamchatka, Russia. XIV. Badalovite, NaNaMg(MgFe3+)(AsO4)3, a member of the alluaudite group
Authors: Pekov Igor V. , Koshlyakova Natalia N. , Agakhanov Atali A. , Zubkova Natalia V. , Belakovskiy Dmitry I. , Vigasina Marina F. , Turchkova Anna G. , Sidorov Evgeny G. , Pushcharovsky Dmitry Yu. 
Published: May 2020

AbstractThe new alluaudite-group mineral badalovite was found in the Arsenatnaya fumarole at the Second scoria cone of the Northern Breakthrough of the Great Tolbachik Fissure Eruption, Tolbachik volcano, Kamchatka, Russia. It is associated with hematite, tenorite, cassiterite, johillerite, nickenichite, calciojohillerite, bradaczekite, metathénardite, aphthitalite, langbeinite, calciolangbeinite, sanidine, fluorophlogopite, fluoborite, tilasite, anhydrite, pseudobrookite, sylvite, halite, lammerite, urusovite, ericlaxmanite, arsmirandite, svabite, krasheninnikovite, euchlorine, wulffite and alumoklyuchevskite. Badalovite forms oblique-angled prismatic crystals up to 1 mm × 1 mm × 5 mm, typically combined in groups or crusts up to several hundred cm2 in area. The mineral is transparent, green, grey, yellow or colourless, with vitreous lustre. It is brittle, the Mohs hardness is 3½. Cleavage was not observed, the fracture is uneven. Dcalc is 4.02 g cm–3. Badalovite is optically biaxial (–), α = 1.753(3), β = 1.757(3), γ = 1.758(3) and 2Vmeas. = 50(10)°. Chemical composition (wt.%, electron-microprobe; holotype) is: Na2O 9.23, K2O 0.19, CaO 2.04, MgO 13.78, MnO 0.31, CuO 0.12, ZnO 0.24, Al2O3 0.06, Fe2O3 12.77, TiO2 0.01, SiO2 0.06, P2O5 0.33, V2O5 0.05, As2O5 61.51, SO3 0.02, total 100.72. The empirical formula based on 12 O apfu is Na1.67Ca0.20K0.02Mg1.92Zn0.02Mn0.02Cu0.01Fe3+0.90Al0.01(As3.01P0.03Si0.01)Σ3.05O12. The simplified formula is Na2Mg2Fe3+(AsO4)3. Badalovite is monoclinic, C2/c, a = 11.9034(3), b = 12.7832(2), c = 6.66340(16) Å, β = 112.523(3)°, V = 936.59(4) Å3 and Z = 4. The strongest reflections of the powder XRD pattern [d,Å(I)(hkl)] are: 6.41(38)(020), 5.505(20)(200), 3.577(23)($\bar{1}$31), 3.523(25)(310), 3.211(46)($\bar{1}$12), 2.911(28)($\bar{2}$22, $\bar{3}$12), 2.765(100)(240, 400) and 2.618(26)($\bar{1}$32). The crystal structure was solved from single-crystal XRD data with an R1 of = 2.49%. Badalovite is isostructural with other alluaudite-group minerals. Its simplified crystal chemical formula is A(1)NaA(1)’□A(2) □A(2)’NaM(1)MgM(2)(Mg0.5Fe3+0.5)2(AsO4)3 (□ – vacancy) and the end-member formula is NaNaMg(MgFe3+)(AsO4)3. The mineral is named in honour of the outstanding mineralogist and geochemist Stepan Tigranovich Badalov (1919–2014).
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Authors: Lewis Natasha E. , Petrova-Drus Kseniya , Huet Sarah , Epstein-Peterson Zachary D. , Gao Qi , Sigler Allison E. , Baik Jeeyeon , Ozkaya Neval , Moskowitz Alison J. , Kumar Anita , Horwitz Steven M. , Zhang Yanming , Arcila Maria E. , Levine Ross L. , Roshal Mikhail , Dogan Ahmet , Xiao Wenbin 
Published: May 2020

Abstract
TET2 and DNMT3A mutations are frequently identified in T-cell lymphomas of T follicular helper cell origin (TCL-TFH), clonal hematopoiesis (CH), and myeloid neoplasms (MNs). The relationships among these 3 entities, however, are not well understood. We performed comprehensive genomic studies on paired bone marrow and tissue samples as well as on flow cytometry–sorted bone marrow and peripheral blood subpopulations from a cohort of 22 patients with TCL-TFH to identify shared CH-type mutations in various hematopoietic cell compartments. Identical mutations were detected in the neoplastic T-cell and myeloid compartments of 15 out of 22 patients (68%), including TET2 (14/15) and DNMT3A (10/15). Four patients developed MNs, all of which shared CH-type mutations with their TCL-TFH; additional unique genetic alterations were also detected in each patient’s TCL-TFH and MN. These data demonstrate that CH is prevalent in patients with TCL-TFH and that divergent evolution of a CH clone may give rise to both TCL-TFH and MNs.
Recurrent lumbar-origin osteoblastoma treated with multiple surgery and carbon ion radiotherapy: a case report
Authors: Honda Akira , Iizuka Yoichi , Imai Reiko , Nishinome Masahiro , Hirato Junko , Koshi Hiromi , Mieda Tokue , Sonoda Hiroyuki , Ishiwata Sho , Kakuta Yohei , Tajika Tsuyoshi , Chikuda Hirotaka 
Published: May 2020

Abstract
Background
Although osteoblastoma is an uncommon benign bone tumor, it sometimes behaves in a locally aggressive fashion. We herein report a case of recurrent lumbar spine osteoblastoma that was treated by repeated surgery and carbon ion radiotherapy.

Case presentation
A 13-year-old Japanese girl presented with left side lumbar pain. Computed tomography and magnetic resonance imaging of the lumbar spine demonstrated a tumorous lesion in the left side pedicle of L4. Although gross total resection of the mass, including the nidus, was performed in the initial surgery, recurrence was observed repeatedly in the short term and the pathological diagnosis of all of the resected tumors was conventional osteoblastoma. We finally performed carbon ion radiotherapy after the patient’s 3rd palliative operation, and achieved a good outcome. No further recurrence has been observed in 10 years of follow-up.

Conclusion
We performed carbon ion radiotherapy for a case of recurrent spinal osteoblastoma and achieved a good outcome without recurrence at 10 years after carbon ion radiotherapy treatment. To the best of our knowledge, this is the first case of osteoblastoma that was treated with carbon ion radiotherapy after multiple surgeries.
Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
Authors: Chen Yi , Lin Yu , Shu Yongqian , He Jing , Gao Wen 
Published: May 2020

AbstractAs a critical internal RNA modification in higher eukaryotes, N6-methyladenosine (m6A) has become the hotspot of epigenetics research in recent years. Extensive studies on messenger RNAs have revealed that m6A affects RNA fate and cell functions in various bioprocesses, such as RNA splicing, export, translation, and stability, some of which seem to be directly or indirectly regulated by noncoding RNAs. Intriguingly, abundant noncoding RNAs such as microRNAs, long noncoding RNAs, circular RNAs, small nuclear RNAs, and ribosomal RNAs are also highly modified with m6A and require m6A modification for their biogenesis and functions. Here, we discuss the interaction between m6A modification and noncoding RNAs by focusing on the functional relevance of m6A in cancer progression, metastasis, drug resistance, and immune response. Furthermore, the investigation of m6A regulatory proteins and its inhibitors provides new opportunities for early diagnosis and effective treatment of cancer, especially in combination with immunotherapy.
Bridging the gap: an economic case study of the impact and cost effectiveness of comprehensive healthcare intermediaries in rural Mexico
Authors: Williamson Anne , de León Lorena Ponce , Garza Francisco Rodríguez , Macías Valeria , Flores Navarro Hugo 
Published: May 2020

Abstract
Background
In rural settings where patients face significant structural barriers to accessing healthcare services, the formal existence of government-provided health coverage does not necessarily translate to meaningful care delivery. This paper analyses the effectiveness of an innovative approach to overcome these barriers, the Right to Health Care programme offered by Compañeros en Salud in Chiapas, Mexico. This programme provides comprehensive free coverage of all additional direct and indirect medical costs as well as accompaniment through the medical system. Over 550 patients had participated from 2013 until November 2018.

Methods
Focusing on ten of the most frequently treated conditions, including hernias, cataracts and congenital heart defects, we performed a retrospective case study analysis of the quality-adjusted life years (QALYs) gained from treatment and the cost per QALY for 69 patients. This analysis used disability weights and uncertainty intervals from the Global Burden of Disease study and organisational micro-costing data for each patient. Each patient was compared to their own hypothetical counterfactual health outcome had they not received the secondary and tertiary care required for the specific condition. A mixed methods approach is used to establish this counterfactual baseline, drawing on pre-intervention observations, qualitative interviews and established literature precedent.

Results
The programme was found to deliver an average of 14.4 additional QALYs (95% uncertainty interval 12.4–15.8) without time discounting. The mean cost per QALY over these conditions was $388 USD (95% UI $262–588) at purchasing power parity.

Conclusions
These numbers compare favourably with studies of other health services and international cost per QALY guidelines. They reflect the on-treatment effect for the ten conditions analysed and are presented as a case study indicative of the promise of healthcare intermediaries rather than a definitive assessment of cost-effectiveness. Nonetheless, these results show the potential feasibility and cost effectiveness of a more comprehensive approach to healthcare provision in a resource-limited rural setting.

Trial registration
This study involves economic analysis of a programme facilitating access to public healthcare services. Thus, there was no associated clinical trial to be registered.
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Authors: Mallet Romain , Modzelewski Romain , Lequesne Justine , Mihailescu Sorina , Decazes Pierre , Auvray Hugues , Benyoucef Ahmed , Di Fiore Fréderic , Vera Pierre , Dubray Bernard , Thureau Sébastien 
Published: May 2020

Abstract
Background
Sarcopenia is defined by a loss of skeletal muscle mass with or without loss of fat mass. Sarcopenia has been associated to reduced tolerance to treatment and worse prognosis in cancer patients, including patients undergoing surgery for limited oesophageal cancer. Concomitant chemo-radiotherapy is the standard treatment for locally-advanced tumour, not accessible to surgical resection. Using automated delineation of the skeletal muscle, we have investigated the prognostic value of sarcopenia in locally advanced oesophageal cancer (LAOC) patients treated by curative-intent chemo-radiotherapy.

Methods
The clinical, nutritional, anthropometric, and functional-imaging (18FDG-PET/CT) data were collected in 97 patients treated between 2006 and 2012 in our institution. The skeletal muscle area was automatically delineated on cross-sectional CT images acquired at the 3rd. lumbar vertebra level and divided by the patient’s squared height (SML3/h2) to obtain the Skeletal Muscle Index (SMI). The primary endpoint was overall survival probability.

Results
Seventy-six deaths were reported. The median survival time was 27 [95% Confidence Interval 23–40] months for the whole population. Univariate analyses (Cox Proportional Hazard Model) showed decreased survival probabilities in patients with reduced SMI, WHO > 0, Body Mass Index ≤21, and Nutritional Risk Index ≤97.5. Multivariate analyses showed that sarcopenia was the only significant prognostic factor (HR 2.32 [1.24–4.34], p = 0.008). Using Receiver Operating Characteristics curves, the Area Under the Curve (AUC) was 0.73 in males (p = 0.0002], the optimal threshold being 51.5 cm2/m2. In women, the AUC was 0.65 (p = 0.19).

Conclusion
Sarcopenia is a powerful independent prognostic factor, associated with a rise of the overall mortality in patients treated exclusively by radiochemotherapy for a locally advanced oesophageal cancer. L3 CT images are easily gathered from 18FDG-PET/CT acquisitions.
In vivo chromatin organization on native yeast telomeric regions is independent of a cis-telomere loopback conformation
Authors: Pasquier Emeline , Wellinger Raymund J. 
Published: May 2020

AbstractBackgroundDNA packaging into chromatin regulates all DNA-related processes and at chromosomal ends could affect both essential functions of telomeres: protection against DNA damage response and telomere replication. Despite this primordial role of chromatin, little is known about chromatin organization, and in particular about nucleosome positioning on unmodified subtelomere–telomere junctions inSaccharomyces cerevisiae.ResultsBy ChEC experiments and indirect end-labeling, we characterized nucleosome positioning as well as specialized protein–DNA associations on most subtelomere–telomere junctions present in budding yeast. The results show that there is a relatively large nucleosome-free region at chromosome ends. Despite the absence of sequence homologies between the two major classes of subtelomere–telomere junctions (i.e.: Y’-telomeres and X-telomeres), all analyzed subtelomere–telomere junctions show a terminal nucleosome-free region just distally from the known Rap1-covered telomeric repeats. Moreover, previous evidence suggested a telomeric chromatin fold-back structure onto subtelomeric areas that supposedly was implicated in chromosome end protection. The in vivo ChEC method used herein in conjunction with several proteins in a natural context revealed no evidence for such structures in bulk chromatin.ConclusionsOur study allows a structural definition of the chromatin found at chromosome ends in budding yeast. This definition, derived with direct in vivo approaches, includes a terminal area that is free of nucleosomes, certain positioned nucleosomes and conserved DNA-bound protein complexes. This organization of subtelomeric and telomeric areas however does not include a telomeric cis-loopback conformation. We propose that the observations on such fold-back structures may report rare and/or transient associations and not stable or constitutive structures.
Optimal dietary copper requirements and relative bioavailability for weanling pigs fed either copper proteinate or tribasic copper chloride
Authors: Lin Gang , Guo Yang , Liu Bing , Wang Ruiguo , Su Xiaoou , Yu Dongyou , He Pingli 
Published: May 2020

Abstract
Background
The objective of this study was to determine the effects of supplementing Cu on growth performance, Cu metabolism and Cu-related enzyme activities of weanling pigs fed diets with two different Cu sources, and to estimate optimal Cu requirements and relative bioavailability from these two sources for pigs.

Methods
Weanling pigs were allocated to 14 treatments arranged factorially, including 6 added Cu levels (5, 10, 20, 40, 80, 160 mg/kg), and 2 mineral sources (tribasic Cu chloride, TBCC and copper proteinate, CuPro), as well as one negative control (0 mg/kg added Cu level) and one maximum allowed level treatment (200 mg/kg TBCC) for the entire 38-d experiment. Growth performance, mineral status and enzyme activities were measured at the end of this study.

Results
Increasing levels of Cu showed linear and quadratic responses (P < 0.01) for final BW, ADG and FCR regardless of the sources. Supplementation with TBCC (> 80 mg/kg) and CuPro (> 20 mg/kg) significantly decreased (P < 0.05) diarrhea incidence of weanling pigs. There were linear and quadratic increases (P < 0.01) in bile, hepatic, and intestinal Cu concentrations, fecal Cu contents, and plasma enzyme activities (alkaline phosphatase, ceruloplasmin, Cu, Zn-Superoxide dismutase (Cu/Zn SOD), and glutathione peroxidase), whereas plasma malondialdehyde decreased (P < 0.01) linearly and quadratically as dietary Cu level increased. Similarly, pigs fed CuPro absorbed and retained more Cu and excreted less Cu than those fed TBCC when supplemented 80 mg/kg and above. Optimal dietary Cu requirements for pigs from 28 to 66 d of age estimated based on fitted broken-line models (P < 0.05) of bile Cu, plasma Cu/Zn SOD and growth performance were 93–140 mg/kg from TBCC, and 63–98 mg/kg from CuPro accordingly. According to slope ratios from multiple linear regression, the bioavailability value of CuPro relative to TBCC (100%) was 156–263% (P < 0.01).

Conclusion
The findings indicated that Cu recommendation from current NRC (5–6 mg/kg) was not sufficient to meet the high requirement of weanling pigs. Cu from CuPro was significantly more bioavailable to weanling pigs than TBCC in stimulating growth and enzyme activities, decreasing diarrhea frequency and fecal Cu contents to the environment.